CN111803596A - Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof - Google Patents

Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof Download PDF

Info

Publication number
CN111803596A
CN111803596A CN202010771123.0A CN202010771123A CN111803596A CN 111803596 A CN111803596 A CN 111803596A CN 202010771123 A CN202010771123 A CN 202010771123A CN 111803596 A CN111803596 A CN 111803596A
Authority
CN
China
Prior art keywords
essential oil
parts
compound aromatic
tea tree
human cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010771123.0A
Other languages
Chinese (zh)
Inventor
刘瑞
彭洁
刘江正
孔德钦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Force Medical University of PLA
Original Assignee
Air Force Medical University of PLA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Force Medical University of PLA filed Critical Air Force Medical University of PLA
Priority to CN202010771123.0A priority Critical patent/CN111803596A/en
Publication of CN111803596A publication Critical patent/CN111803596A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of essential oil, in particular to compound aromatic essential oil for improving the antioxidant activity of human cells and application thereof. The compound essential oil is prepared from the following raw materials in parts by weight: 30-40 parts of tea tree essential oil, 10-20 parts of citronella essential oil and 40-60 parts of mint essential oil. The invention also provides application of the compound aromatic essential oil in preparing a medicament for preventing and treating microsome lipid peroxidation through an olfactory pathway in a targeted manner. The compound aromatic essential oil can effectively reduce microsomal lipid peroxidation induced by different factors, reduce the level of intracellular oxide and improve the level of antioxidant, and meanwhile, the raw materials are all pure natural plant essences, so that no side effect is caused in the using process.

Description

Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof
Technical Field
The invention relates to the technical field of essential oil, in particular to compound aromatic essential oil for improving the antioxidant activity of human cells and application thereof.
Background
Harmful gases such as human metabolic waste gas exist in a plurality of closed spaces, and the health state of personnel is influenced and the operation capability is reduced when the personnel operates in the environment for a long time. Researches find that oxidative stress is a main action mechanism of external harmful factors, most toxic and harmful gases attack macromolecules in organisms to cause organism damage by generating various forms of free radicals, and damage can be reduced by directly resisting the free radicals by using a free radical scavenger or an antioxidant or by improving the antioxidant capacity of the organisms, so that the search for substances capable of eliminating the harmful gases and reducing the substances capable of inducing the oxidative stress of the organisms is very important for improving the environment and the health of people.
Most of the existing natural extracts with the deodorization function only report that the natural extracts can eliminate free radicals and oxidation resistance in a chemical system, and the effect on organisms, particularly human bodies is unknown. The radical scavenger or antioxidant, which is commonly used in organisms, has not been found to have the effect of improving air quality, and its effect cannot be conveniently achieved by inhalation.
Disclosure of Invention
The invention provides a compound aromatic essential oil for improving the antioxidant activity of human cells, which comprises the following raw materials in parts by weight:
30-40 parts of tea tree essential oil, 10-20 parts of citronella essential oil and 40-60 parts of mint essential oil.
The second aspect of the invention provides application of the compound aromatic essential oil in preparing a medicament for preventing and treating microsome lipid peroxidation through an olfactory pathway in a targeted manner.
Further, the medicine is prepared from the following raw materials in parts by weight:
30-40 parts of tea tree essential oil, 10-20 parts of citronella essential oil, 40-60 parts of mint essential oil and 5-10 parts of absolute ethyl alcohol.
Further, the medicament is a spray.
Further, the preparation method of the spray comprises the following steps:
weighing 30-40 parts of tea tree essential oil, 10-20 parts of citronella essential oil, 40-60 parts of mint essential oil and 5-10 parts of absolute ethyl alcohol according to the mass parts, and mixing the tea tree essential oil, the citronella essential oil, the mint essential oil and the absolute ethyl alcohol to obtain a finished spray product.
Compared with the prior art, the invention has the following technical effects:
the compound aromatic essential oil for improving the antioxidant activity of human cells provided by the invention can effectively reduce the level of intracellular oxides and improve the level of antioxidants, and meanwhile, the raw materials are all pure natural plant essences, so that no side effect is caused in the use process.
Detailed Description
The present invention is described in detail below with reference to specific examples, but the present invention should not be construed as being limited thereto. The technical means used in the following examples are conventional means well known to those skilled in the art, and materials, reagents and the like used in the following examples can be commercially available unless otherwise specified.
Examples 1 to 4 and comparative examples 1 to 6
Weighing the raw materials according to the corresponding data in the table 1, and uniformly mixing the raw materials with 8kg of absolute ethyl alcohol by stirring to obtain the compound aromatic essential oil.
Table 1 complex essential oil formula table unit: kg of
Figure BDA0002615937940000031
Measurement indexes are as follows:
applications H2O2Treating L02 cells to make oxidative stress model, and determining the influence of different proportions of essential oil on cell oxidative stress, wherein the indexes include cell activity (CCK8), Reactive Oxygen Species (ROS) level, Malondialdehyde (MDA) content, Catalase (CAT) activity, glutathione peroxidase (GSH-Px) activity, and superoxide dismutase (SOD) activity. The above measurements were carried out according to the corresponding commercial kit (Nanjing Biotechnology Co., Ltd.). Simultaneously setting blank control (adding culture medium only) and solvent control (adding culture medium and H)2O2) Positive drug control (culture medium plus H)2O2Adding Vc after treatment) and essential oil (culture medium plus H)2O2Followed by treatment with essential oil) and the results are shown in table 2.
Table 2 results of cellular oxidative stress test (n ═ 3)
Figure BDA0002615937940000032
Figure BDA0002615937940000041
As can be seen from Table 2, in the influence of cellular oxidative stress at different ratios, compared with solvent control, the CCK8, CAT,/GSH-Px and SOD levels of examples 1-4 are obviously increased, and MDA and ROS are obviously reduced, which shows that the formulas of examples 1-4 can reduce the intracellular oxide level and improve the antioxidant level, compared with comparative examples 1-6, the comprehensive effect of examples 1-4 is better, therefore, the mass ratio of the tea tree essential oil, the citronella essential oil and the mint essential oil is determined to be 30-40: 10-20: 40-60.
It should be noted that the steps and methods adopted in the claims of the present invention are the same as those of the above-mentioned embodiments, and for the sake of avoiding redundancy, the present invention describes the preferred embodiments, but those skilled in the art can make other changes and modifications to these embodiments once they learn the basic inventive concept. Therefore, it is intended that the appended claims be interpreted as including preferred embodiments and all such alterations and modifications as fall within the scope of the invention.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.

Claims (5)

1. The compound aromatic essential oil for improving the antioxidant activity of human cells is characterized by comprising the following raw materials in parts by weight:
30-40 parts of tea tree essential oil, 10-20 parts of citronella essential oil and 40-60 parts of mint essential oil.
2. The use of the complex essential oil of claim 1 in the preparation of a medicament for the targeted prevention and treatment of microsomal lipid peroxidation via the olfactory pathway.
3. The use of claim 2, wherein the medicament is composed of the following raw materials in parts by weight:
30-40 parts of tea tree essential oil, 10-20 parts of citronella essential oil, 40-60 parts of mint essential oil and 5-10 parts of absolute ethyl alcohol.
4. The use according to claim 3, wherein the medicament is a spray.
5. The use according to claim 4, wherein the spray is prepared by the following process:
weighing 30-40 parts of tea tree essential oil, 10-20 parts of citronella essential oil, 40-60 parts of mint essential oil and 5-10 parts of absolute ethyl alcohol according to the mass parts, and mixing the tea tree essential oil, the citronella essential oil, the mint essential oil and the absolute ethyl alcohol to obtain a finished spray product.
CN202010771123.0A 2020-08-03 2020-08-03 Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof Pending CN111803596A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010771123.0A CN111803596A (en) 2020-08-03 2020-08-03 Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010771123.0A CN111803596A (en) 2020-08-03 2020-08-03 Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof

Publications (1)

Publication Number Publication Date
CN111803596A true CN111803596A (en) 2020-10-23

Family

ID=72863526

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010771123.0A Pending CN111803596A (en) 2020-08-03 2020-08-03 Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof

Country Status (1)

Country Link
CN (1) CN111803596A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199773A (en) * 2007-12-21 2008-06-18 北京中科雍和医药技术有限公司 Compound essential oil of refreshing thinker
CN102973972A (en) * 2012-12-28 2013-03-20 青岛信锐德科技有限公司 Rosemary leaf mosquito-repelling air freshener and preparation method
CN102989025A (en) * 2012-12-28 2013-03-27 青岛信锐德科技有限公司 Camphor tree leaf mosquito repellent air fresher and preparation method
CN106265148A (en) * 2016-08-27 2017-01-04 广东罗浮山国药股份有限公司 A kind of perfume containing natural plant essential oils and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199773A (en) * 2007-12-21 2008-06-18 北京中科雍和医药技术有限公司 Compound essential oil of refreshing thinker
CN102973972A (en) * 2012-12-28 2013-03-20 青岛信锐德科技有限公司 Rosemary leaf mosquito-repelling air freshener and preparation method
CN102989025A (en) * 2012-12-28 2013-03-27 青岛信锐德科技有限公司 Camphor tree leaf mosquito repellent air fresher and preparation method
CN106265148A (en) * 2016-08-27 2017-01-04 广东罗浮山国药股份有限公司 A kind of perfume containing natural plant essential oils and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
孙伟等: "16种芳香植物精油抗氧化活性的比较研究 ", 《食品科技》 *
温朋飞等: "植物精油抗氧化作用机制研究进展", 《饲料工业》 *

Similar Documents

Publication Publication Date Title
CN104491904B (en) A kind of air freshener
CN113528384B (en) Preparation method of double-split yeast fermentation product, product and application thereof
CN101658207A (en) Method for controlling microorganism in wheat flour
WO2013081331A1 (en) Skin preparation composition for external use having excellent antiseptic ability
Yapar et al. Protective effect of kombucha mushroom (KM) tea on phenol-induced cytotoxicity in albino mice
CN103503930A (en) Botanical pesticide composition and application thereof
Jin et al. Study of postharvest quality and antioxidant capacity of freshly cut amaranth after blue LED light treatment
CN108125810A (en) A kind of compound moisturizing remediation composition and its preparation method and application
CN111803596A (en) Compound aromatic essential oil for improving antioxidant activity of human cells and application thereof
CN110448495A (en) A kind of cosmetic composition with collaboration antioxidant effect
CN107349156A (en) A kind of plant composition and its preparation method and application
Chedea et al. Antibacterial action of an aqueous grape seed polyphenolic extract
Meijer-Severs et al. Short-chain fatty acids and succinate in feces of healthy human volunteers and their correlation with anaerobe cultural counts
KR102394531B1 (en) Antiseptic containing caprylic/capric glycerides and composition for skin external application containing thereof
JPH09278666A (en) Antimicrobial agent and its production
CN111643705B (en) Essential oil composition and application thereof in preparation of air freshener
Xu et al. Evaluation of the antimicrobial mechanism of biogenic selenium nanoparticles against Pseudomonas fluorescens
CN113491663A (en) Superoxide dismutase composition and preparation method thereof
Škraban et al. Comparative genomics of Acetobacter and other acetic acid bacteria
Adewunmi et al. A potential molluscicide, aridan (Tetrapleura tetraptera), neither induces chromosomal alterations in Chinese Hamster ovary cells, nor mutations in Salmonella typhimurium
Chou et al. Evaluation of antioxidative and mutagenic properties of 50% ethanolic extract from red beans fermented by Aspergillus oryzae
Chee et al. In vitro activity of celery essential oil against Malassezia furfur
Susatyo et al. Antioxidant Effect of Clorella vulgaris on Wistar Rat Kidney Induced by CCl4: A Histopathological Review
CN112870114A (en) Natural moisturizing composition and preparation method thereof
CN101984804B (en) Corpse preservation solution and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination